Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-18-001956
Filing Date
2018-03-14
Accepted
2018-03-14 16:52:52
Documents
1
Period of Report
2018-03-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4_pimstone031418.html 4  
1 OWNERSHIP DOCUMENT f4_pimstone031418.xml 4 6580
  Complete submission text file 0001171843-18-001956.txt   7912
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
PIMSTONE SIMON N. (Reporting) CIK: 0001620084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 18690058